Journal of Clinical & Experimental Dermatology Research
Open Access
ISSN: 2155-9554
+44 1478 350008
ISSN: 2155-9554
+44 1478 350008
Ylfete A Shatri-Mucaj, Gentiana Mu�?§aj, Thanas Furreraj, Faik Shatri, Mybera Ferizi and Nazife Hajdini-Ahmetaj
Gentiana GreLorGen Clinic, Kosova
University Clinic Center in Prishtina, Kosova
Scientific Tracks Abstracts: J Clin Exp Dermatol Res
The changes in the skin in the form of brown spots (hyperpigmentation) at humans, pose an aesthetic problem but also more a health problem/issue. Hyperpigmentation is presented in most of cases in the face region, but they do not spare other body also. During my research and the treatment of my patients, in my professional experience I have gone through patients with hyperpigmentation with different etiologies. Hyperpigmentation have multietiology. In most of the cases, they are signs that indicate and support us to find many internal disorders of the body and organism, just as an ID reaction to many diseases as: Endocrine (hormonal disorder), fungal infections, autoimmune disease (Morphea), therapeutic (either systemic or local), application of cosmetic preparations and combined. In the time period July 2010-2015, in the clinic ��?GENTIANA GreLorGen� in Prishtina (Republic of Kosova), there have been treated in total 378 patients for various forms of hyperpigmentation, from whom, 34 male (9%) and 344 female (91%). These patients, in this research have been categorized in groups based on the etiology: Patients with Endocrine (hormonal disorders) etiology (Group I); Patients with Autoimmune disease etiology (Group II); Patients with Mycotic (fungal) infections etiology (Group III); Patients with Local and systemic therapeutics etiology (Group IV); Patients with Cosmetic etiology (Group V); and Patients with different/combined etiology (Group VI). Depending on the hyperpigmentation etiology, beside the local therapy with magisterial preparations, proper field specialists have been consulted as: Endocrinologist, Gynecologist, Cardiologist and Rheumatologist. In addition, beside the local treatment with magisterial preparations as personal cream: ALBA-HYNOGEN, ALBA HYNOGEN M2, LORGEN SUN DAY, PREVITA-GEN, DEPEORKET, DEPEOR-GEN, ITRA-PEN, LOTTI FLU GEN, JORA-XH, PERIORB GEN, ANTISEP-CONT and ANTISEP-V. Patients have been treated with additional physical therapy as: MKDB (Micro dermo abrasion) combined with therapy. In conclusion, hyperpigmentation treatment requires a proper multidisciplinary research and diagnostification, depending on its etiology and appearance.
Ylfete A Shatri-Muçaj is a Clinical Dermatovenerology and Pharmacology Specialist for specialization of Clinical Pharmacology is one of the first generations for basic specialization in this field in Balkans. She has completed her Post graduation and specialization studies from the University of Novi Sad. Currently, she works in UCC in Prishtina from 1981 as a Specialist of Clinical Pharmacology. She has treated patients with chemotherapy for 4 years in Internal Clinic, Department of Hematology in UCC. She has led laboratory for many years for magisterial preparations in the Center Pharmacy and Dermatovenerology Clinic, CUU in Prishtina. She has also worked for some years in the Institute of Biochemistry, Diagnostic Center of CUU. Since 2001, she is working as a Clinical Dermatovenerologist and Pharmacologist in KDV and currently leads Dermatological Polyclinic and Laboratory for Magisterial Preparations for several skin diseases and aesthetic issues through that she treats patients in the polyclinic “GENTIANA GreLorGen”. She is a Member of EADV and Kosovo Association of Dermatovenerologists and Oncologists.
Email: grelorgen@yahoo.com